Growing Awareness and Technology Push RSV Vaccine Market Beyond US$ 15 Bn

The global respiratory syncytial virus (RSV) vaccine market is on a steep growth trajectory, driven by increasing awareness of RSV’s health impact, technological advancements in vaccine development, and rising hospitalization rates among infants and ...